| Date |
Research Question / Title |
Unique ID |
Research Team |
|
June 7, 0222
|
What is the efficacy of a 4th booster dose for COVID-19?
|
EOC220304v002 RR Table
|
EOC
|
|
April 6, 2020
|
What is the evidence for the effectiveness of face masks for preventing the spread of COVID-19 in the community?
|
EOC040601 RR
|
EOC
|
|
April 23, 2020
|
What sampling method is most appropriate for population testing?
|
LAB042201 RR
|
Laboratory
|
|
April 25, 2020
|
What frequency of repeat population screening will be required?
|
LAB042202 RR
|
Laboratory
|
|
July 27, 2020
|
What is the definition of an outbreak versus a cluster for COVID-19 in different clinical and community settings in Canada, the US, and the UK?
|
EOC071001 RR
|
EOC
|
|
September 17, 2020
|
What evidence is there to support medical exemptions for mask wearing?
|
EOC091101 RR
|
EOC
|
|
September 29, 2020
|
What is the evidence that runny nose or sneezing are symptoms of COVID-19?
|
EOC092401 RR
|
EOC
|
|
December 17, 2020
|
How is COVID-19 transmitted from person-to-person and what is the most common source of transmission?
|
INF121501 RR
|
Infectious Disease
|
|
December 17, 2020
|
How is COVID-19 transmitted from person-to-person and what is the most common source of transmission?
|
INF121501 RR Table
|
Infectious Disease
|
|
March 12, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401 RR
|
Public Health
|
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR Table
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR Table
|
EOC
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general
population?
|
EOC210902 RR Table
|
EOC
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
|
December 20, 2021
|
What is the epidemiology of variants and what are the implications for healthcare? [Evergreen]
|
EOC031801v019 RR Table
|
EOC
|
|
December 20, 2021
|
What is the epidemiology of variants and what are the implications for healthcare? [Evergreen]
|
EOC031801v019 RR
|
EOC
|
|
December 22, 2021
|
What is the epidemiology of the Omicron variant and its impact on health care?
|
EOC211220 RR Table
|
EOC
|
